MYHIXEL III: Analyzing a Third-Gen Male Sexual Health Device's $820K Crowdfunding Success

Campaign Teardown · · PledgeRadar Editorial

MYHIXEL III: Analyzing a Third-Gen Male Sexual Health Device's $820K Crowdfunding Success

MYHIXEL III is the third-generation smart training device from MYHIXEL, a Spanish brand focused on male sexual health. Designed as a home-based training tool, it caters to adult men seeking to improve ejaculation control or address psychogenic erectile dysfunction, leveraging a combination of simulated stimulation, heating and vibration systems, motion sensors, and an in-app behavioral training curriculum.

Campaign Performance and Brand History

MYHIXEL III launched on Kickstarter on December 10, 2024, and concluded its campaign on February 7, 2025, ultimately securing over $820,000 from nearly 3,300 backers. The project quickly surpassed its funding goal within hours of launch, attracting 769 supporters and over $150,000 in its first 48 hours.

The campaign's marketing strategy included Kickstarter early bird discounts and an affiliate program on Kickbooster offering a 10% commission. This was further bolstered by a loyal user base from MYHIXEL's previous two products, content focused on male health, and endorsements from medical experts, all of which directly drove traffic to the third-generation device.

MYHIXEL has a history of successful crowdfunding. Its first project in 2018 for MYHIXEL I raised $76,715 from 519 backers. The 2022 campaign for MYHIXEL Control/MYHIXEL II achieved €540,000 with 2,791 backers. The third generation's success, surpassing $800,000, marks a new crowdfunding record for the brand, validating user demand across three consecutive product iterations.

Following the campaign, MYHIXEL announced it was coordinating logistics, with the first rewards expected to ship in the coming days. This isn't the first time the brand has faced such issues; the 2022 MYHIXEL II campaign also experienced production and logistics delays, with some backers waiting until the second half of 2023. Despite these challenges, the brand's ability to successfully fund three projects suggests that while delivery issues may arise, there is a commitment to resolving them.

文章图片

Core Product Features and Innovation

**38℃ Simulated Training Structure:** MYHIXEL III features an anatomically designed TPE inner sleeve with an upgraded heating system that reaches approximately 38℃, close to human body temperature. It also incorporates an adjustable suction structure to vary internal resistance. The device measures approximately 113×113×215mm and weighs about 615g. The true value of this design lies not merely in increasing stimulation, but in making behavioral training as close to real-life scenarios as possible. MYHIXEL's long-term product logic is that if users only practice control in low-stimulation environments, the training effect may not smoothly transfer to real-life scenarios. However, the concept of "realistic simulation" lacks a unified objective standard, and individual perceptions of temperature, pressure, and material can vary significantly.

**5 Targeted Vibration Modes:** The third generation features repositioned vibration motors and offers five distinct vibration modes. Three modes are primarily designed for ejaculation control training, utilizing different frequencies to vary stimulation. The other two modes are engineered for erection training, employing specific stimulation rhythms to help users maintain arousal. This represents a clear upgrade from previous generations, which simply added a vibration function, as MYHIXEL III now designs hardware modes specifically for different training objectives. It's important to note that claims of improving erection quality cannot be directly deduced from the vibration modes alone. The brand's ED courses primarily target psychogenic/performance anxiety-related erectile difficulties and are not a substitute for medical evaluation of vascular, neurological, hormonal, or other organic causes of ED.

**Motion Sensor and Bluetooth Connectivity:** The device integrates a gyroscope and accelerometer, connecting via Bluetooth to the MYHIXEL Hub. This allows it to record motion and speed data during training, which is then translated into progress statistics within the app. This feature creates a genuine product distinction between MYHIXEL and conventional adult stimulation devices. While ordinary products focus on immediate experience, MYHIXEL aims to track changes between training sessions and continuously adjust content through its software courses. However, these data points are best suited as training feedback rather than medical diagnostic indicators.

**8-Week Control Course:** While MYHIXEL III can be used independently, its complete core functionality is realized through MYHIXEL Control. This is an 8-week ejaculation control training course that integrates cognitive behavioral training, body response recognition, and progressive stimulation exercises. Users then utilize the device to simulate high-stimulation environments for practice. This aspect represents MYHIXEL's most significant commercial differentiation compared to typical delay sprays. Products like Promescent aim to reduce sensitivity for a single instance, whereas MYHIXEL endeavors to help users build sustained control capabilities over several weeks of training. MYHIXEL does possess clinical evidence; a 2021 multi-center randomized controlled trial published in PLOS ONE, involving 40 lifelong premature ejaculation patients, showed that individuals using the MYHIXEL device combined with 8 weeks of Sphincter Control Training experienced a greater improvement in Intravaginal Ejaculatory Latency Time (IELT) compared to a control group receiving training alone. The device group's average improvement factor at the end of treatment was approximately 4.27.

**5-8 Week ED Training:** A notable functional expansion in MYHIXEL III compared to its predecessors is the addition of the MYHIXEL ED Program. This course, lasting approximately 5-8 weeks, primarily targets psychogenic erectile issues, encompassing understanding sources of anxiety, gradually reducing performance pressure, and incorporating simulated training with MYHIXEL III. This approach is inherently sound, as sexual performance anxiety and difficulties in maintaining an erection can indeed reinforce each other. However, its scope of applicability must also be clearly defined. MYHIXEL itself primarily describes this course as targeting psychogenic ED. It is not an equivalent treatment solution for organic ED caused by conditions such as diabetes, cardiovascular disease, medication side effects, or hormonal imbalances.

文章图片

Design, Durability, and Company Vision

**IPX7 Waterproofing and USB-C:** MYHIXEL III boasts IPX7 waterproofing and upgrades from its previous proprietary charging interface to USB-C. Official documentation indicates that a single charge provides enough power for approximately three training sessions. The device is constructed from materials like ABS, Silicone, and TPE. For a product requiring frequent cleaning, waterproofing is arguably more practical than simply adding more vibration modes. The third generation also increases the number of control buttons from two to three, reducing the need to rely solely on a smartphone for basic operation.

MYHIXEL's parent company is headquartered in Seville, Spain. Founder Patricia, who initially worked in tourism and marketing, entered the US adult product industry in 2014, focusing on marketing. She observed a significant gap in the market for long-term training products addressing issues like premature ejaculation and performance anxiety, with most male sexual health products concentrating on entertainment and immediate gratification. This insight led her to establish MYHIXEL. The company gradually shifted its product positioning from "adult products" to "Male Sexual Wellness," incorporating expertise from sexologists, urologists, and psychologists during development. In terms of delivery, the brand has successfully sold and shipped its first and second-generation devices. The official Trustpilot page features hundreds of public reviews, which are generally positive, though there are also numerous lower-rated comments regarding Kickstarter delays and customer service responsiveness.

Global Market Analysis and Strategic Positioning

According to data updated by Fortune Business Insights in 2026, the global Sexual Wellness Products market is projected to reach approximately $26.84 billion in 2025, $28.82 billion in 2026, and grow to $52.84 billion by 2034, with a Compound Annual Growth Rate (CAGR) of about 7.87% from 2026 to 2034. If the scope includes SexTech, encompassing connected adult hardware and digital experiences, the market is expected to expand from $57.9 billion in 2026 to $107.9 billion by 2030, representing a CAGR of 16.7% from 2025 to 2030. The significant difference in these market figures primarily stems from varying statistical boundaries.

MYHIXEL does not compete in the typical adult product price range. For premature ejaculation, delay sprays like Promescent start at around $22.95, offering a solution for a single instance. For erection issues, devices like the Mystery Vibe Tenuto 2, a wearable vibrator, are priced at approximately $175. The MYHIXEL III, with early bird Kickstarter pricing starting around $180, positions itself as a hardware-plus-long-term-training solution, integrating digital courses and behavioral training. Its true differentiation isn't merely stronger vibration or more realistic materials, but rather packaging multi-week behavioral training into a connected hardware device and app. This approach allows it to command a premium with a "medical health narrative."

However, risks are also concentrated in this area. Firstly, the efficacy of sexual health treatments inherently exhibits significant individual variation. Secondly, the brand's most compelling randomized controlled clinical evidence involves a sample size of only 40 individuals and pertains to an earlier device and PE training, not all the new features of the third generation. Thirdly, by positioning MYHIXEL III to address both PE and psychogenic ED, the marketing scope has expanded, but the clinical evidence has not synchronously extended to all advertised effects.

Despite these considerations, MYHIXEL III has demonstrated that male users are willing to pay for home-based, private, non-pharmacological, long-term sexual health training. Other similar projects also indicate the market potential for such products.

MYHIXEL III has demonstrated that male users are willing to pay for home-based, private, non-pharmacological, long-term sexual health training.